Zenas BioPharma, Inc. (ZBIO)
NASDAQ·Healthcare·Biotechnology
$28.53
+4.51%
Mkt Cap $1.78B
Analyst Ratings
Buy
7
Hold
2
Sell
0
Price Target (9 analysts)
$43.50
Range $32.00 – $55.00
Implied Upside
+52.5%
Consensus $43.50 vs current $28.53
NASDAQ·Healthcare·Biotechnology
$28.53
+4.51%
Mkt Cap $1.78B
Buy
7
Hold
2
Sell
0
Price Target (9 analysts)
$43.50
Range $32.00 – $55.00
+52.5%
Consensus $43.50 vs current $28.53